Long-term outcomes of reverse shoulder arthroplasty versus nonoperative treatment for 3- or 4-part proximal humerus fractures in elderly patients: results from a prior randomized clinical trial.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2025;13(15):5 J Shoulder Elbow Surg . 2025 Jun;34(6):1463-1470.What this means for my practice?
RSA provides superior long-term functional outcomes compared to nonoperative treatment for displaced 3- or 4-part proximal humerus fractures in very elderly patients, largely due to deterioration in the nonoperative group over time. Clinically, this supports considering RSA when life expectancy is sufficient to realize these benefits. A key limitation is the small sample size from attrition and mortality in this aged cohort.
Study Summary
Twenty-nine elderly patients (≥80 years) with displaced 3- or 4-part proximal humerus fractures were randomized to receive reverse shoulder arthroplasty (RSA) (n=17) or nonoperative treatment (n=12). The primary outcome was the Constant score. Secondary outcomes included Disabilities of the Arm, Shoulder and Hand (DASH) score, range of motion (ROM), pain (VAS), SF-12, EQ-5D, and radiographic findings. Outcomes were assessed at a mean follow-up of approximately 7.5 years. Overall, the results revealed that RSA achieved significantly higher Constant scores and better ROM, with no significant differences in quality-of-life measures or pain. Radiographically, all nonoperative cases healed in malposition without revision, whereas one RSA patient required revision for dislocation. These findings suggest that RSA offers superior long-term functional outcomes due to deterioration over time in the nonoperative group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!